Sabby Management’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Sabby Management’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$132K	Buy	+42,559	New	+$176K	0.29%	20
2025 Q4	–	Sell	-70,303	Closed	-$871K	–	39
2025 Q3	$871K	Buy	70,303 +31,316	+80%	+$478K	1.01%	10
2025 Q2	$819K	Buy	+38,987	New	+$898K	1.48%	10
2019 Q3	–	Sell	-1,059	Closed	-$610K	–	97
2019 Q2	$610K	Buy	+1,059	New	+$1.16M	0.77%	28
2018 Q3	–	Sell	-37	Closed	-$130K	–	131
2018 Q2	$130K	Sell	37 -372	-91%	-$1.48M	0.02%	110
2018 Q1	$1.77M	Buy	+409	New	+$2.26M	0.21%	43
2017 Q2	–	Sell	-10	Closed	-$57K	–	225
2017 Q1	$57K	Buy	+10	New	+$60.7K	﹤0.01%	245

Other funds holding CANF

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Sabby Management's CANF Position: Q1 2026 in Review

Sabby Management opened a new position in Can-Fite BioPharma American Depositary Shares (CANF) in Q1 2026: 42,559 shares worth $132K. The stake represents 0.29% of the portfolio and ranks #20 among its holdings. This is a return to the name: Sabby Management previously reported a position in CANF as recently as Q3 2025.

Sabby Management first reported a position in CANF in Q1 2017 and has held it in 7 quarters since. The position peaked at $1.77M in Q1 2018. 14 funds tracked by Wall St. Rank hold CANF as of Q1 2026.

Sabby Management held 42,559 shares of Can-Fite BioPharma American Depositary Shares worth $132K as of Q1 2026.
Can-Fite BioPharma American Depositary Shares was a new Sabby Management position in Q1 2026.
Can-Fite BioPharma American Depositary Shares made up 0.29% of Sabby Management's portfolio in Q1 2026, its #20 holding.
Sabby Management first reported a position in Can-Fite BioPharma American Depositary Shares in Q1 2017 and has held it in 7 quarters since.
Sabby Management's Can-Fite BioPharma American Depositary Shares position peaked at $1.77M in Q1 2018.
14 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q1 2026.

Based on Sabby Management's 13F filing for Q1 2026, filed 15 May 2026.